These data suggest that SRSF1 may contribute to the pathogenesis of ALL as an anti-apoptotic factor through an interaction with PRMT1, and SRSF1 may potentially represent a sensitive predictor of relapse. Here, SRSF1 is linked to acute lymphoblastic leukemia.